Endometrial cancer and hormone-replacement therapy in the Million Women Study (Q34415404)

2 August 2017

title

Endometrial cancer and hormone-replacement therapy in the Million Women Study (English)

1 reference

Hormone Replacement Therapy

2 August 2017

main subject

1 reference

1 reference

1

Valerie Beral

1 reference

Million Women Study Collaborators

2 August 2017

series ordinal

4

object named as

Million Women Study Collaborators

1 reference

2 August 2017

3

Gillian Reeves

1 reference

2 August 2017

Diana Bull

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

2 August 2017

1 reference

2 August 2017

volume

365

1 reference

2 August 2017

issue

9470

1 reference

2 August 2017

page(s)

1543-1551

1 reference

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Estrogen-Progestin Replacement Therapy and Endometrial Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Continuous combined hormone replacement therapy and risk of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Carcinoma of the endometrium in patients treated with tibolone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Tibolone and endometrial cancer: a cohort and nested case-control study in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Breast cancer and hormone-replacement therapy in the Million Women Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Adipose tissue as a source of hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966455-0

7 January 2021

10.1016/S0140-6736(05)66455-0

Identifiers

DOI

1 reference

2 August 2017

1 reference